IuMeDa SRL
The score of IuMeDa shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +68 % Total assets +25 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
IuMeDa's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 May 2026
- Year ended 31 Dec 2024filed on 26 May 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
IuMeDa's financial analysis
- Solvency92.1%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of IuMeDa
IuMeDa's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0786.944.964
- VAT number
- BE0786944964
- Peppol
- Registered · 0208:0786944964 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Jun 2022
- Registered office
- 3010 Leuven
- Latest accounts
- 2025 · filed on 27 May 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
IuMeDa (SRL) has been based in Leuven since 2022, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 12,011 € and equity of 61,038 €; its revenue is not published. Its solvency stands at 92.1%, above the median of its sector (60.4%).
Companies similar to IuMeDa
Companies in the same business, of comparable size and area, outside its group.
- Pharmaplex Research and experimental development on natural sciences and engineering Wezembeek-Oppem · balance sheet 482,967 €
- KST R & D Research and experimental development on natural sciences and engineering Liège · balance sheet 65,816 €
- "Clinical & Quality Support" Research and experimental development on natural sciences and engineering Villers-la-Ville · balance sheet 67,856 €
- Pharma Health Consulting & Services Business and other management consultancy activities La Louvière · balance sheet 73,329 €
- Green Patriotism Research and experimental development on natural sciences and engineering Mortsel · balance sheet 123,338 €
- VirAdvice Research and experimental development on natural sciences and engineering Leuven · balance sheet 75,092 €
- JW Hoste Research and experimental development on natural sciences and engineering Ghent · balance sheet 61,802 €
- icode Research and experimental development on natural sciences and engineering Walhain · balance sheet 79,376 €
Frequently asked questions about IuMeDa
What is the revenue of IuMeDa?
IuMeDa files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of IuMeDa?
In Belgium, the VAT number is the company number prefixed with BE: BE0786944964 for IuMeDa, if the company is VAT-registered. Its company number (CBE) is 0786.944.964.
Where is the registered office of IuMeDa?
According to the CBE register, the registered office of IuMeDa is in 3010 Leuven.
What is the equity of IuMeDa?
At the close of the 2025 financial year, the equity of IuMeDa amounts to 61,038 €, a solvency of 92.1% of total assets.
Who manages IuMeDa?
The register lists 2 active mandates at IuMeDa. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of IuMeDa
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →